Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


JAMA Study Suggests Antibiotic Use Among Premature Infants May Be Unnecessarily High: Public Health Watch
Increased stewardship may reduce administration of drugs to low birth-weight babies designed to prevent early-onset sepsis.
Extra Weight Linked with Increased Survival in Some Patients with Infectious Diseases
The results of 2 studies indicate that patients who are overweight or obese have better mortality outcomes than patients who are at a normal weight when it comes to fighting off infectious diseases.
United States Sees Drop in Rate of HPV Vaccination Course Completion
Despite public health recommendations, a new study has found that too many adolescents and young adults in the United States are failing to complete the full vaccination course for HPV.
Study on Infection Prevention Programs Find Urgent Need for Increased Staffing
A new study finds that most infection prevention and control programs require more staff and existing models are woefully inadequate.
Top 5 Infectious Disease News of the Week—May 20, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Don't Discount Low Efficiency Influenza Vaccines
With optimal distribution, even low-efficacy flu vaccines can make a difference, although their benefits vary somewhat depending on which age group has a high uptake rate.
Human Factors Engineering Improves Effectiveness of Ambulatory Antibiotic Stewardship
Ambulatory antibiotic stewardship interventions are more effective when focused on tools, technology, the person, organization, tasks, and environment components.
Exploring Cephalosporin/β-Lactamase Inhibitor Combinations for Treatment of <i>Pseudomonas</i>
Peter Salgo, MD; Yoav Golan, MD; Andrew Shorr, MD; and Marin Hristos Kollef, MD, provide their perspective on the cephalosporin/β-lactamase inhibitor combinations Zerbaxa, Avycaz, and Vabomere, with considerations for mechanisms of action and effectiveness.
Big advances in treatment can